Rocket Lab’s Stock Sinks Below a Key Threshold as Neutron Progress and Insider Sales Pull in Opposite Directions
Published on 07/26/2026 at 15:02 | Redaktion boerse-global.de
Rocket Lab USA closed Friday at $63.91, shedding 8.69% in a single session and breaching the $67.50 floor tied to its planned Iridium acquisition. That technical breakdown has erased roughly $20.4 billion in market value over the past month, overshadowing a string of operational wins that would normally command investor attention. The stock now sits 57.68% below its 52-week high of $151.00, a reminder of the volatility that has come to define this corner of the space sector.
The Iridium floor matters because it sets the exchange ratio for the all-stock deal that would transform Rocket Lab into a vertically integrated space platform. Falling beneath that level shifts the deal’s economics in ways that add another layer of uncertainty to an already turbulent narrative. For a company that just posted a record first quarter — $200.3 million in revenue, up 63.5% year over year — the market’s reaction feels disconnected from the underlying business.
An Engine Test and a Pentagon Win
Behind the stock’s slide, the engineering team is hitting its marks. The Archimedes engine, which will power the first stage of the Neutron rocket, completed a full-duration test burn. Eight of those engines will generate 1.5 million pounds of thrust, enough to lift 13,000 kilograms to orbit. Rocket Lab still targets the first half of 2026 for Neutron’s maiden flight, a milestone that would open access to a market worth over $10 billion.
The government pipeline is thickening as well. The U.S. Department of Defense awarded Rocket Lab a $190 million contract for 20 hypersonic technology test flights using the HASTE vehicle, spread over four years. That award pushes the company’s total launch backlog past 70 missions, with an aggregate value exceeding $2 billion. The contract book now stands at $2.2 billion, underpinning a three-year average revenue growth rate of 44.51%.
Should investors sell immediately? Or is it worth buying Rocket Lab USA?
Space Systems now accounts for 68% of revenue, a structural shift that diversifies the business beyond pure launch services. The Mynaric acquisition, completed in early 2026, added laser-communication technology that management describes as a step toward becoming the “Intel of space.” The patent portfolio grew 18% year over year, concentrated in carbon-fiber manufacturing and automated satellite-bus production.
The Other Side of the Ledger
None of that has stopped the selling. CEO Peter Beck unloaded roughly 3.29 million shares over the past six months, collecting about $287.7 million. The largest tranches moved on July 7 and 8 at prices between $82.86 and $84.92. Institutional holders including KBC Group and Lido Advisors also trimmed their positions in the first quarter of 2026.
The research-and-development spend — 44% of revenue — reflects the intensity of qualifying the Archimedes engines and preparing Neutron for flight. That burn rate weighs on profitability, with analysts expecting an adjusted EBITDA loss between $20 million and $26 million when Rocket Lab reports second-quarter results on August 10. Revenue guidance for that quarter sits between $225 million and $240 million.
Morgan Stanley remains bullish, maintaining an Overweight rating with a bull-case target of $293, driven by Neutron’s potential in the second half of 2026. The broader analyst consensus is more tempered, pegging the average 12-month price target at $110.18 — still implying roughly 72% upside from current levels. Piper Sandler’s target of $100 for AST SpaceMobile, by contrast, sits closer to that stock’s recent trading range.
A Sector Under Pressure
The broader space index fell 4.20% on Friday, dragged lower by a sector-wide selloff that has punished both high-flyers and established operators. Rocket Lab’s one-month decline of 37.38% far exceeds the index’s 12.40% drop over the same period, while its one-year gain of 31.74% still outpaces the sector’s 18.90% advance. The stock’s beta of 1.85 confirms it moves harder than the market in both directions.
Rocket Lab USA at a turning point? This analysis reveals what investors need to know now.
AST SpaceMobile, the other marquee name in the NewSpace trade, fell 5.04% on Friday and has lost 22.87% over the past month. Its beta of 2.45 signals even wider swings. But the two companies occupy fundamentally different positions: Rocket Lab is generating real revenue from a proven launch cadence and a growing space-systems business, while AST SpaceMobile is burning $1.1 billion in free cash flow as it builds out its BlueBird constellation with $3.5 billion in cash reserves.
What Comes Next
The Neutron first flight, now expected in the first half of 2026, is the single most important catalyst on Rocket Lab’s calendar. A successful debut would validate the architecture and unlock a medium-lift market that could push annual revenue past $1 billion. The non-GAAP gross margin on the Electron rocket has stabilized at 43%, providing a template for what Neutron might deliver at scale.
But the stock’s path between now and that milestone depends on whether the market can look past the Iridium floor breach, the insider selling, and the macro headwinds that have crushed space equities across the board. The August 10 earnings call will offer the next test of conviction — and a chance for management to reframe the narrative around execution rather than volatility.
Ad
Rocket Lab USA Stock: New Analysis - 26 July
Fresh Rocket Lab USA information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
